AnaptysBio | 8-K: Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
AnaptysBio | 10-Q: Quarterly report
AnaptysBio | SC 13G: Statement of acquisition of beneficial ownership by individuals-James N. Topper(7.0%),Patrick J. Heron(6.8%), etc.
AnaptysBio | ARS: Annual Report to Security Holders
AnaptysBio | DEF 14A: Definitive information statements
AnaptysBio | DEFA14A: Others
AnaptysBio | 4: Statement of changes in beneficial ownership of securities-Officer Faga Daniel
AnaptysBio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AnaptysBio | 10-K: Annual report
AnaptysBio | 8-K: Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
AnaptysBio | 4: Statement of changes in beneficial ownership of securities-Officer LOUMEAU ERIC J
AnaptysBio | 144: Notice of proposed sale of securities pursuant to Rule 144
AnaptysBio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(7.3%),Tang Capital Management, LLC(7.3%), etc.
AnaptysBio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.0%),Point72 Capital Advisors, Inc.(3.0%), etc.
AnaptysBio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(7.67%),Deep Track Biotechnology Master Fund, Ltd.(7.67%), etc.
AnaptysBio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.19%)
AnaptysBio | 4: Statement of changes in beneficial ownership of securities-Officer MULROY DENNIS
AnaptysBio | 144: Notice of proposed sale of securities pursuant to Rule 144
AnaptysBio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.8%)
AnaptysBio | 4: Statement of changes in beneficial ownership of securities-Officer Lizzul Paul F.
No Data